Potential of N-acetylcysteine in the management of low back pain: a scoping review of studies in humans and animal models
Brazilian Journal of Medical and Biological Research,
Journal Year:
2025,
Volume and Issue:
58
Published: Jan. 1, 2025
Low
back
pain
(LBP)
is
a
common
type
of
that
causes
disability
and
impairs
cognitive
function.
With
over
80%
adults
estimated
to
experience
LBP
during
their
lifetime,
this
not
only
has
significant
impact
on
the
individual,
but
also
public
health
systems
national
economies.
Unfortunately,
there
no
single
standard
care
for
patients
with
LBP.
N-acetylcysteine
(NAC),
which
used
clinically
treat
acetaminophen
overdose,
recently
been
tested
as
potential
treatment
NAC
inexpensive
commercially
available,
it
an
established
tolerance
safety
profile.
However,
NAC's
efficacy
in
established.
This
scoping
review
presents
summary
studies
investigating
effects
benefits
treatment,
highlights
its
molecular
mechanisms
side
effects.
A
systematic
literature
search
Pubmed/MEDLINE,
Embase,
Scopus,
Science
Direct,
Web
Science,
Cinahl,
Lilacs
databases
was
conducted.
The
PRISMA-ScR
checklist
ensure
integrity
review.
protocol
registered
Open
Framework.
No
limit
set
study
language
publication
date.
In
total,
2357
articles
were
located,
16
included.
show
data
are
derived
from
few
clinical
trials
preclinical
studies.
Thus,
much
learn
more
should
be
performed
before
can
recommended
Language: Английский
Preclinical Animal Models to Investigate the Role of Nav1.7 Ion Channels in Pain
Álvaro Yogi,
No information about this author
Umberto Banderali,
No information about this author
María Moreno
No information about this author
et al.
Life,
Journal Year:
2025,
Volume and Issue:
15(4), P. 640 - 640
Published: April 12, 2025
Chronic
pain
is
a
maladaptive
neurological
disease
that
remains
major
global
healthcare
problem.
Voltage-gated
sodium
channels
(Navs)
are
drivers
of
the
excitability
sensory
neurons,
and
Nav
subtype
1.7
(Nav1.7)
has
been
shown
to
be
critical
for
transmission
pain-related
signaling.
This
highlighted
by
demonstrations
gain-of-function
mutations
in
Nav1.7
gene
SCN9A
result
various
pathologies,
whereas
loss-of-function
cause
complete
insensitivity
pain.
A
substantial
body
evidence
demonstrates
chronic
neuropathy
inflammation
an
upregulation
Nav1.7,
suggesting
this
channel
contributes
sensation.
As
such,
attractive
human-validated
target
treatment
Nonetheless,
lack
selectivity,
insufficient
efficacy,
adverse
reactions
some
issues
have
hindered
Nav1.7-targeted
drug
development.
review
summarizes
behavior
profiles
mediated
reported
multiple
preclinical
models,
outlining
current
knowledge
biophysical,
physiological,
distribution
properties
required
inhibitor
produce
analgesia.
Language: Английский
Incorporación de la perspectiva de género en proyectos I+D+i en salud. Cuándo y cómo
Medicina Clínica,
Journal Year:
2025,
Volume and Issue:
165(1), P. 106963 - 106963
Published: May 21, 2025
P2X3 and P2X2/3 Receptors Inhibition Produces a Consistent Analgesic Efficacy: A Systematic Review and Meta-Analysis of Preclinical Studies
European Journal of Pharmacology,
Journal Year:
2024,
Volume and Issue:
984, P. 177052 - 177052
Published: Oct. 10, 2024
P2X3
and
P2X2/3
receptors
are
promising
therapeutic
targets
for
pain
treatment
selective
inhibitors
under
evaluation
in
ongoing
clinical
trials.
Here
we
aim
to
consolidate
quantitatively
evaluate
the
preclinical
evidence
on
treatment.
Language: Английский
Fucoidan as a Promising Drug for Pain Treatment: Systematic Review and Meta-Analysis
Marine Drugs,
Journal Year:
2024,
Volume and Issue:
22(7), P. 290 - 290
Published: June 24, 2024
Fucoidan
is
a
polymer
of
L-fucose
and
L-fucose-4-sulphate
naturally
found
in
marine
sources
that
inhibits
p-selectin,
preventing
neutrophil
recruitment
to
the
site
injury.
employed
many
studies
as
tool
investigate
contribution
neutrophils
pain,
showing
analgesic
effects.
We
performed
systematic
review
meta-analysis
quantify
effects
pretreatment
with
fucoidan
reported
available
preclinical
studies.
In
addition,
we
summarized
articles
which
have
studied
therapeutic
pathological
pain
at
clinical
levels.
The
results
this
reveal
powerful
reduces
infiltration
by
70–90%
early
time
points.
This
showed
preventative
treatment
produced
significant
reduction.
several
observed
associated
various
pathologies.
Finally,
has
also
been
tested
trials,
some
degree
efficacy,
but
they
were
mostly
small
pilot
Considering
all
above
information,
it
can
be
concluded
not
only
for
studying
role
promising
strategy
treatment.
Language: Английский
The role of neutrophils in pain: systematic review and meta-analysis of animal studies
Pain,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Oct. 25, 2024
Abstract
The
peripheral
inflammatory
response
is
an
attractive
therapeutic
target
for
pain
treatment.
Neutrophils
are
the
first
circulating
cells
recruited
to
sites
of
injury,
but
their
contribution
outcomes
unclear.
We
performed
a
systematic
review
and
meta-analysis
original
preclinical
studies,
which
evaluated
effect
preemptive
neutrophil
depletion
on
(PROSPERO
registration
number:
CRD42022364004).
Literature
search
(PubMed,
January
19,
2023)
identified
49
articles,
were
meta-analyzed
using
random-effects
model.
risk
bias
was
SYRCLE's
tool.
pooled
considering
all
studies
showed
that
induced
consistent
reduction.
Inflammatory,
joint,
neuropathic,
visceral
significant
alleviation
by
with
medium-large
sizes.
However,
muscle
postoperative
not
significantly
alleviated
depletion.
Further
analysis
differential
neutrophils
outcomes.
had
higher
impact
mechanical
hyperalgesia,
followed
nociceptive
behaviors
allodynia,
smaller
thermal
hyperalgesia.
Interspecies
(mice
or
rats)
differences
appreciated.
Analyses
regarding
intervention
unveiled
lower
reduction
some
commonly
used
methods
depletion,
such
as
injection
antineutrophil
serum
anti–Gr-1
antibody,
than
other
agents
administration
anti-Ly6G
fucoidan,
vinblastine,
CXCR1/2
inhibitors,
etanercept.
In
conclusion,
depends
etiology
(experimental
model),
outcome,
strategy.
research
needed
improve
our
understanding
mechanisms
these
differences.
Language: Английский